Compare PDEX & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDEX | STIM |
|---|---|---|
| Founded | 1978 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.5M | 105.5M |
| IPO Year | 1995 | 2018 |
| Metric | PDEX | STIM |
|---|---|---|
| Price | $39.00 | $1.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $56.00 | $7.00 |
| AVG Volume (30 Days) | 19.5K | ★ 2.4M |
| Earning Date | 05-04-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 345.00 | N/A |
| EPS | ★ 2.07 | N/A |
| Revenue | ★ $66,593,000.00 | $52,776,000.00 |
| Revenue This Year | $7.22 | $101.67 |
| Revenue Next Year | N/A | $10.87 |
| P/E Ratio | $19.09 | ★ N/A |
| Revenue Growth | ★ 23.68 | N/A |
| 52 Week Low | $23.52 | $1.25 |
| 52 Week High | $70.26 | $5.91 |
| Indicator | PDEX | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 44.93 | 38.38 |
| Support Level | $37.07 | $1.41 |
| Resistance Level | $41.09 | $2.13 |
| Average True Range (ATR) | 1.57 | 0.21 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 29.60 | 0.60 |
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.